Are Endocan Plasma Levels Altered in Preeclampsia?

Ana Cristina dos Santos Lopes; Suellen Rodrigues Martins; Luci Maria SantAna Dusse; Melina de Barros Pinheiro; Patrícia Nessralla Alpoim

doi:10.1055/s-0041-1728661

Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics, Table of Contents

CC BY 4.0 · Rev Bras Ginecol Obstet 2021; 43(03): 232-234
DOI: 10.1055/s-0041-1728661

Letter to the Editor

Are Endocan Plasma Levels Altered in Preeclampsia?

Ana Cristina dos Santos Lopes

¹Department of Clinical and Toxicological Analysis, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil

,

Suellen Rodrigues Martins

¹Department of Clinical and Toxicological Analysis, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil

,

Luci Maria SantAna Dusse

¹Department of Clinical and Toxicological Analysis, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil

,

Melina de Barros Pinheiro

²Universidade Federal de São Joao del-Rei, Divinópolis, MG, Brazil

,

Patrícia Nessralla Alpoim

¹Department of Clinical and Toxicological Analysis, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil

› Author Affiliations

Abstract

Full Text

References

References
1 Dusse L, Godoi L, Kazmi RS, Alpoim P, Petterson J, Lwaleed BA. et al. Sources of thrombomodulin in pre-eclampsia: renal dysfunction or endothelial damage?. Semin Thromb Hemost 2011; 37 (02) 153-157
2 Dusse LM, Alpoim PN, Lwaleed BA, de Sousa LP, Carvalho Md, Gomes KB. Is there a link between endothelial dysfunction, coagulation activation and nitric oxide synthesis in preeclampsia?. Clin Chim Acta 2013; 415: 226-229
3 Pinheiro MB, Carvalho MG, Martins-Filho OA, Freitas LG, Godoi LC, Alpoim PN. et al. Severe preeclampsia: are hemostatic and inflammatory parameters associated?. Clin Chim Acta 2014; 427: 65-70
4 Alpoim PN, Godoi LC, Freitas LG, Pinheiro MdeB, Gomes KB, Dusse LM. Is intraplatelet cGMP jeopardized to inhibit platelet activation in severe preeclampsia?. Blood Coagul Fibrinolysis 2015; 26 (06) 711-713
5 Lucena FC, Lage EM, Teixeira PG, Barbosa AS, Diniz R, Lwaleed B. et al. Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia. Hypertens Pregnancy 2019; 38 (01) 58-63
6 Pinheiro MB, Martins-Filho OA, Mota AP, Alpoim PN, Godoi LC, Silveira ACO. et al. Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state. Cytokine 2013; 62 (01) 165-173
7 Perucci LO, Gomes KB, Freitas LG, Godoi LC, Alpoim PN, Pinheiro MB. et al. Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia. PLoS One 2014; 9 (05) e97632
8 Alpoim PN, Godoi LC, Freitas LG, Gomes KB, Dusse LM. Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia. Nitric Oxide 2013; 33: 81-82
9 Alpoim PN, Gomes KB, Pinheiro MdeB, Godoi LC, Jardim LL, Muniz LG. et al. Polymorphisms in endothelial nitric oxide synthase gene in early and late severe preeclampsia. Nitric Oxide 2014; 42: 19-23
10 Alpoim PN, Perucci LO, Godoi LC, Goulart COL, Dusse LMS. Oxidative stress markers and thrombomodulin plasma levels in women with early and late severe preeclampsia. Clin Chim Acta 2018; 483: 234-238
11 American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
12 Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367 (9516): 1066-1074
13 Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33 (03) 130-137
14 Kali A, Shetty KS. Endocan: a novel circulating proteoglycan. Indian J Pharmacol 2014; 46 (06) 579-583
15 Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Celik T, Iyisoy A. Endocan: A novel inflammatory indicator in cardiovascular disease?. Atherosclerosis 2015; 243 (01) 339-343
16 Yuksel MA, Tuten A, Oncul M, Acikgoz AS, Yuksel IT, Toprak MS. et al. Serum endocan concentration in women with pre-eclampsia. Arch Gynecol Obstet 2015; 292 (01) 69-73
17 Cakmak M, Yilmaz H, Bağlar E, Darcin T, Inan O, Aktas A. et al. Serum levels of endocan correlate with the presence and severity of pre-eclampsia. Clin Exp Hypertens 2016; 38 (02) 137-142
18 Chang X, Bian Y, Wu Y, Huang Y, Wang K, Duan T. Endocan of the maternal placenta tissue is increased in pre-eclampsia. Int J Clin Exp Pathol 2015; 8 (11) 14733-14740
19 Hentschke MR, Lucas LS, Mistry HD, Pinheiro da Costa BE, Poli-de-Figueiredo CE. Endocan-1 concentrations in maternal and fetal plasma and placentae in pre-eclampsia in the third trimester of pregnancy. Cytokine 2015; 74 (01) 152-156
20 Chew BS, Ghazali R, Othman H, Ismail NAM, Othman AS, Laim NMST. et al. Endocan expression in placenta of women with hypertension. J Obstet Gynaecol Res 2019; 45 (02) 345-351
21 Adekola H, Romero R, Chaemsaithong P, Korzeniweski SJ, Dong Z, Yeo L. et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med 2015; 28 (14) 1621-1632
22 Hentschke MR, da Cunha Filho EV, Vieira MC, Paula LG, Mistry HD, Costa BEP. et al. Negative correlation between placental growth factor and endocan-1 in women with preeclampsia. Rev Bras Ginecol Obstet 2018; 40 (10) 593-598
23 Schuitemaker JHN, Cremers TIFH, Van Pampus MG, Scherjon SA, Faas MM. Changes in endothelial cell specific molecule 1 plasma levels during preeclamptic pregnancies compared to healthy pregnancies. Pregnancy Hypertens 2018; 12: 58-64
24 Delehedde M, Devenyns L, Maurage CA, Vivès RR. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol 2013; 2013: 705027
25 Shin JW, Huggenberger R, Detmar M. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood 2008; 112 (06) 2318-2326
26 Rios DRA, Alpoim PN, Godoi LC, Perucci LO, Sousa LR, Gomes KB. et al. Increased levels of sENG and sVCAM-1 and decreased levels of VEGF in severe preeclampsia. Am J Hypertens 2016; 29 (11) 1307-1310